| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
cinaciguat
|
329773-35-5 |
CINACIGUAT
|
|
C36H39NO5 |
565.69856 | |
|
ICI 118,551 hydrochloride
|
72795-01-8 |
ICI 118,551 HYDROCHLORIDE
|
ICI 118551 盐酸盐;CS-769
|
C17H28ClNO2 |
313.86272 | |
|
KU 0060648
|
881375-00-4 |
KU-6648
|
KU0060648;KU 0060648;CS-768
|
C33H35N4O4S |
583.7204 | |
|
CUDC-907
|
1339928-25-4 |
CUDC-97
|
N-羟基-2-[[[2-(6-甲氧基吡啶-3-基)-4-(吗啉-4-基)噻吩并[3,2-D]嘧啶-6-基]甲基](甲基)氨基]嘧啶-5-甲酰胺
|
C23H24N8O4S |
508.55286 | |
|
PQ 401
|
196868-63-0 |
PQ 41
|
N-(5-氯-2-甲氧基苯基)-N'-(2-甲基-4-喹啉基)脲;PQ-401;PQ 401
|
C18H16ClN3O2 |
341.796 | |
|
Okadaic acid
|
78111-17-8 |
冈田(软海绵)酸
|
35-去甲基鳍藻毒素 1;软海绵酸(>95.0%,BC);冈田(软海绵)酸溶液,10PPM;大田软海绵酸;冈田酸游离酸;软海绵酸,游离酸;冈田(软海绵)酸;冈田酸
|
C44H68O13 |
805 | 616-589-8 |
|
PTC124 (Ataluren)
|
775304-57-9 |
Ataluren (PTC124)
|
3-[5-(2-氟苯基)-1,2,4-恶二唑-3-基]苯甲酸
|
C15H9FN2O3 |
284.24 | 922-364-8 |
|
AG-17
|
10537-47-0 |
酪氨酸磷酸化抑制剂A9
|
TYRPHOSTIN 9;MALONOBEN;TYRPHOSTIN AG-17;SF 6847;GCP 5126;RG-50872;NSC 242557;CS-743;酪氨酸磷酸化抑制剂A9;3,5-二叔丁基-4-羟基亚苄基丙二腈;丙螨氰;TYRPHOSTIN 9;NSC 242557;RG-50872;AG 17;GCP 5126;酪氨酸磷酸化抑制剂A9>98%
|
C18H22N2O |
282.38 | |
|
pirinixic acid
|
50892-23-4 |
匹立尼酸
|
[4-氯-6-(2,3-二甲代苯氨基)-2-嘧啶基]乙酸;CS-737;WY14643;PIRINIXIC ACID;WY 14643;WY-14643;皮利尼克酸;匹立尼酸;[4-氯-6-(2,3-茬胺基)-3-嘧啶硫代]乙酸
|
C14H14ClN3O2S |
323.8 | |
|
Forskolin
|
66575-29-9 |
佛司可林
|
福斯高林;佛司可林,来源于毛喉鞘蕊花;福斯高林,毛喉萜,考福新,锦紫苏醇;佛司可林(福斯高林,锦紫苏醇);弗斯可林;毛喉鞘蕊
|
C22H34O7 |
410.5 | 266-410-9 |
|
AVL-292
|
1202757-89-8 |
AVL292
|
CC-292;AVL292;AVL-292;AVL 292;CC-292;AVL292;AVL-292;AVL 292;SPEBRUTINIB;CS-733;N-[3-[[5-氟-2-[[4-(2-甲氧基乙氧基(苯基]氨基]-4-嘧啶基]氨基]苯基]-2-丙烯酰胺
|
C22H22FN5O3 |
423.440183 | |
|
AZD3463
|
1356962-20-3 |
AZD3463
|
AZD3463;AZD 3463;ALK;IGF1R INHIBITOR;N-[4-(4-氨基-1-哌啶基)-2-甲氧基苯基]-5-氯-4-(1H-吲哚-3-基)-2-嘧啶胺;AZD3463;AZD3463;AZD 3463;CS-729
|
C24H25ClN6O |
448.9479 | |
|
GSK343
|
1346704-33-3 |
GSK343
|
1-异丙基-N-[(6-甲基-2-氧代-4-丙基-1,2-二氢-3-吡啶基)甲基]-6-[2-(4-甲基-1-哌嗪基)-4-吡啶基]-1H-吲唑-4-甲酰胺;1-异丙基-N-[(6-甲基-2-氧代-4-丙基-1;GSK343;GSK 343;GSK-343;CS-728;2-二氢-3-吡啶基)甲基]-6-[2-(4-甲基-1-哌嗪基)-4-吡啶基]-1H-吲唑-4-甲酰胺;N-[(6-METHYL-2-OXO-4-PROPYL-1H-PYRIDIN-3-YL)METHYL]-6-[2-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-4-YL]-1-PROPAN-2-YLINDAZOLE-4-CARBOXAMIDE
|
C31H39N7O2 |
541.68706 | |
|
1-[5-(2,3-Dichloro-phenylsulfanyl)-4-nitro-thiophen-2-yl]-ethanone
|
882257-11-6 |
P591
|
CS-726;P5091;P-005091;P 005091;P 5091;P-5091;1-[5-[(2,3-二氯苯基)硫基]-4-硝基-2-噻吩基]-乙酮
|
C12H7Cl2NO3S2 |
348.22488 | |
|
EPZ005687
|
1396772-26-1 |
EPZ5687
|
EPZ-005687;EPZ 00568;1-CYCLOPENTYL-N-((4,6-DIMETHYL-2-OXO-1,2-DIHYDROPYRIDIN-3-YL)METHYL)-6-(4-(MORPHOLINOMETHYL)PHENYL)-;CS-724;EPZ005687;EPZ005687;EPZ-005687
|
C32H37N5O3 |
539.66788 | |
|
PJ34
|
344458-15-7 |
PJ34
|
PI34;PJ 34;PJ-34;CS-723;N-(6-氧代-5,6-二氢菲啶-2-基)-2-(N,N-二甲基氨基)乙酰胺盐酸盐;PJ 34 盐酸盐
|
C17H17N3O2HCl |
316.78208 | |
|
SR1078
|
1246525-60-9 |
SR178
|
N-[4-[2,2,2-三氟-1-羟基-1-(三氟甲基)乙基]苯基]-4-(三氟甲基)苯甲酰胺;SR1078;SR 1078;SR-1078;SR 1078;SR-1078;SR1078,N-[4-(2,2-TRIFLUORO-1-HYDROXY-1-TRIFLUOROMETHYL-ETHYL)-PHENYL]-4-TRIFLU
|
C17H10F9NO2 |
431.252429 | |
|
Lumacaftor
|
936727-05-8 |
VX89
|
卢卡福杂质;罗马卡托;VX-809 + IVACAFTOR;3-(6-{[1-(2,2-二氟苯并[1,3]二氧代-5-基)-环丙烷羰基]-氨基}-3-甲基-吡啶-2-基)苯甲酸;VX809;VX-809;鲁玛卡托;CS-719;3-[6-[[[1-(2,2-二氟-1,3-苯并二氧戊环-5-基)环丙基]羰基]氨基]-3-甲基-2-吡啶基]苯甲酸
|
C24H18N2O5F2 |
452.40692 | |
|
1-(tert-Butyl)-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
172889-27-9 |
PP2
|
3-(4-氯苯基)-1-叔丁基-1H-吡唑并[3,4-D]嘧啶-4-胺;3-(4-氯苯基)1-(1,1-二甲基乙基)-1H-吡唑并[3,4-D]嘧啶-4-胺;CS-717;PP 2;AG1879;AG 1879;AGL 1879;PP2;AGL 1879;PP 2;PP-2
|
C15H16ClN5 |
301.77 | |
|
1-(tert-Butyl)-3-(p-tolyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
172889-26-8 |
蛋白磷酸酯酶-1(抗原)
|
PP1;PP 1;PP-1.;蛋白磷酸酯酶-1(抗原);CS-716;PP1;PP 1;PP-1;AGL 1872;EI 275;1-叔丁基-3-(4-甲基苯基)-1H-吡唑并[3,4-D]嘧啶-4-胺;蛋白磷酸酯酶-1(抗体)
|
C16H19N5 |
281.36 |
药智官方微信
药智官方微博
